Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Xtremepicks Alerts Message Board

$ZGNX Recent Headlines Zogenix to cut 37% of w

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 89397
Posted On: 08/06/2014 12:29:30 PM
Avatar
Posted By: Stock_Tracker
$ZGNX Recent Headlines

Zogenix to cut 37% of workers to stretch its cash 9:38 a.m. June 5, 2013 - MarketWatch.com
Zogenix: FDA decision may be delayed past March 1 2:17 p.m. Feb. 27, 2013 - MarketWatch.com
Small is beautiful, tiny is even better 7:00 a.m. Jan. 2, 2013 - Mark Hulbert
Monday’s big movers: Mr. Dimon goes to Washington 6:16 p.m. Dec. 10, 2012 - Sue Chang
Zogenix offers 32.5M units of shares and warrants 10:40 a.m. July 24, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 3:35 p.m. July 16, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 5:36 p.m. March 9, 2012 - Kate Gibson
Updates, advisories and surprises 3:01 p.m. March 9, 2012 - MarketWatch
Zogenix tumbles on earnings report 2:04 p.m. March 9, 2012 - Val Brickates Kennedy
Zogenix climbs on earnings speculation 2:06 p.m. March 5, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:44 p.m. Jan. 6, 2012 - Kate Gibson
Zogenix puts 7.8% discount on 30 mln–share offer 1:44 p.m. Sept. 16, 2011 - MarketWatch.com
Zogenix to sell 12 mln shares to fund new drug 7:50 a.m. Aug. 24, 2011 - MarketWatch.com
Zogenix to seek FDA approval of chronic-pain drug 9:00 a.m. Aug. 17, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 5:41 p.m. Jan. 3, 2011 - MarketWatch
Anacor, Zogenix IPOs delayed 5:59 p.m. Nov. 19, 2010 - Val Brickates Kennedy

Zogenix's (ZGNX) CEO Roger Hawley on Q2 2014 Results - Earnings Call Transcript 10:14 p.m. Aug. 5, 2014 - Seeking Alpha
Zogenix (ZGNX) Q2 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 5, 2014 - Seeking Alpha
Zohydro Gains Massachusetts Approval, Acts As Minor Catalyst For Zogenix 1:24 p.m. Aug. 5, 2014 - benzinga.com
Zogenix Announces Departure of Chief Commercial Officer, Scott Shively 3:05 p.m. Aug. 1, 2014 - benzinga.com
FDA approves Purdue's oxycodone 5:33 p.m. July 23, 2014 - Seeking Alpha
Despite The Sell-Off, Zohydro Is A Falling Knife Too Dangerous To Catch 6:48 a.m. July 22, 2014 - Seeking Alpha
Zogenix Announces David Brushwood, J.D., R.Ph., Joins External Safe Use Board 7:31 a.m. July 17, 2014 - benzinga.com
New patent for DosePro 8:49 a.m. July 14, 2014 - Seeking Alpha
Zogenix takes it on the chin due to looming competitive threat 3:59 p.m. July 8, 2014 - Seeking Alpha
Zogenix Has Partial Victory in Zohydro Court Battle 2:59 p.m. July 8, 2014 - The Wall Street Journal Interactive Edition
Why Zogeniz (ZGNX) Stock Is Tumbling Today 11:27 a.m. July 8, 2014 - TheStreet.com
Purdue pain pill gets priority review 7:16 a.m. July 8, 2014 - Seeking Alpha
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 8:51 a.m. July 3, 2014 - Zacks.com
AcelRx Should Trend Higher As FDA Approval Is Likely At End Of This Month 8:30 a.m. July 2, 2014 - Seeking Alpha
Zogenix progresses on abuse deterrent versions of Zohydro 7:54 a.m. July 2, 2014 - Seeking Alpha
Zogenix Provides Update On Development Of Abuse Deterrent Formulations Of Zohydro ER 6:36 a.m. July 2, 2014 - benzinga.com
Imminent District Court Ruling Should Propel Zogenix Higher 10:19 a.m. June 20, 2014 - Seeking Alpha
Mallinckrodt pain drug NDA accepted 8:34 a.m. May 28, 2014 - Seeking Alpha
New Painkiller Sparks Abuse Concern 7:07 p.m. May 23, 2014 - The Wall Street Journal Interactive Edition
Zogenix (ZGNX) CEO Roger Hawley on Q1 2014 Results - Earnings Call Transcript 9:47 p.m. May 8, 2014 - Seeking Alpha


Zogenix Announces Departure of Chief Commercial Officer, Scott Shively 4:06 p.m. Aug. 1, 2014 - GlobeNewswire
Technical Coverage on Pharma Stocks -- GlaxoSmithKline, TherapeuticsMD, AstraZeneca, Zogenix, and Novartis 9:10 a.m. July 22, 2014 - PR Newswire - PRF
Zogenix Announces Conference Call and Webcast to Present Second Quarter 2014 Financial Results 9:00 a.m. July 22, 2014 - GlobeNewswire
Zogenix Announces Appointment of David Brushwood, J.D., R.Ph., to External Safe Use Board 8:31 a.m. July 17, 2014 - GlobeNewswire
Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System 8:31 a.m. July 14, 2014 - GlobeNewswire
Zogenix Reports Positive Development on U.S. District Court Ruling 8:31 a.m. July 9, 2014 - GlobeNewswire
Kosher Certifications, Biologic License Applications, Positive Study Results, Development Programs, and Product Acquisitions - Analyst Notes on Pfizer, Novartis, Sanofi, Zogenix and Impax 6:40 a.m. July 7, 2014 - PR Newswire - PRF
Zogenix Provides Update on Development of Abuse Deterrent Formulations of Zohydro(R) ER 7:31 a.m. July 2, 2014 - GlobeNewswire
Technical Roundup on Health Care Sector Stocks -- Research on HCA Holdings, Community Health Systems, GlaxoSmithKline, and Zogenix 7:50 a.m. June 23, 2014 - PR Newswire - PRF
Zogenix to Present at Two Upcoming Conferences 4:30 p.m. June 16, 2014 - GlobeNewswire
Zogenix Reports Granting of Inducement Awards 6:40 p.m. June 2, 2014 - GlobeNewswire
Zogenix Officers to Report Withholding of Shares 9:36 a.m. June 2, 2014 - GlobeNewswire
Zogenix to Present at Jefferies 2014 Global Healthcare Conference 9:02 a.m. May 30, 2014 - GlobeNewswire
Equities Updates on Top Gainers -- Research on Comstock Resources, Zogenix, Mercadolibre, and Clovis Oncology 8:00 a.m. May 30, 2014 - PR Newswire - PRF
Relief Efforts, Rights Acquisitions, Recognition, and Settlements - Analyst Notes on UnitedHealth Group, Endo, Baxter, Edwards Lifesciences and Aetna 7:00 a.m. May 23, 2014 - PR Newswire - PRF
Endo Completes Acquisition of Rights to Sumavel® DosePro® 7:34 a.m. May 19, 2014 - PR Newswire - PRF
Zogenix Closes Sale of SUMAVEL(R) DosePro(R) Migraine Therapy to Endo International 7:31 a.m. May 19, 2014 - GlobeNewswire
Zogenix Reports First Quarter 2014 Financial Results 4:03 p.m. May 8, 2014 - GlobeNewswire
Stock Updates on Health Care Sector Bellwethers -- Research on IMS Health Holdings, Illumina, Novartis, and Zogenix 10:48 a.m. May 6, 2014 - PR Newswire - PRF
Zogenix Reports Granting of Inducement Awards 4:06 p.m. May 2, 2014 - GlobeNewswire



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us